Regeneron, Sanofi arthritis drug fails Covid-19 study

Biotech company Regeneron said its rheumatoid arthritis drug Kevzara failed to meet the main goals of a US study testing it in the most critically ill Covid-19 patients
Regeneron, Sanofi arthritis drug fails Covid-19 study
Fri, 03 Jul, 2020 - 17:48
Alan Healy

Previous trial results had also shown that the drug did not help patients with less severe Covid-19.
Previous trial results had also shown that the drug did not help patients with less severe Covid-19.

Additional reporting: Reuters

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

Benefit image

Introductory offer. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €12/month. Ts&Cs apply.

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Electric car stock Electric car sales surge by 70% in Ireland, but Tesla's decline continues
empty J1 USA visa for man US visa crackdown is an assault on students' rights
Sad boy standing alone in the hallway Derval McDonagh: We cannot say what happened to Grace will not happen again 
CoronavirusPlace: USPlace: LimerickPlace: United StatesPlace: New YorkPlace: DellPlace: RaheenPerson: RegeneronPerson: Chief Scientific OfficerPerson: George YancopoulosOrganisation: SanofiOrganisation: RegeneronOrganisation: CovidOrganisation: ReutersOrganisation: Roche Holding AGOrganisation: ActemraOrganisation: US Food and Drug Administration
<p>EY Ireland chief economist Loretta O'Sullivan said trade fragmentation is a challenge for Ireland’s economic model,</p>

EY forecasts GDP growth of 9% in 2025 and 3.3% next year

READ NOW

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Latest

Business

Push Notifications

By clicking on sign up you will be the first to know about a selection of business content on this browser. Please note if you are unable to sign up via your mobile web browser, download and sign up for mobile push notifications via our FREE news app.

Sign Up
IE logo
Devices


UNLIMITED ACCESS TO THE IRISH EXAMINER FOR TEAMS AND ORGANISATIONS
FIND OUT MORE

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Fergus Finlay
Fergus Finlay

Analysis

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited